WFA of San Diego’s abrdn Life Sciences Investors HQL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-300
Closed -$4.65K 411
2025
Q3
$4.65K Hold
300
﹤0.01% 357
2025
Q2
$3.84K Buy
+300
New +$3.7K ﹤0.01% 370
2024
Q3
$4.52K Hold
300
﹤0.01% 322
2024
Q2
$4.25K Buy
+300
New +$4.06K ﹤0.01% 325
2023
Q3
$3.74K Hold
300
﹤0.01% 328
2023
Q2
$4.06K Buy
+300
New +$4.14K ﹤0.01% 319
2023
Q1
Sell
-300
Closed -$4.26K 207
2022
Q4
$4.26K Buy
+300
New +$4.35K ﹤0.01% 415
2022
Q3
Sell
-300
Closed -$4K 203
2022
Q2
$4K Buy
+300
New +$4.53K ﹤0.01% 332

Other funds holding HQL

WFA of San Diego's HQL Position: Q4 2025 in Review

WFA of San Diego sold out of abrdn Life Sciences Investors (HQL) in Q4 2025, closing a stake of 300 shares — an estimated $4.65K sold.

WFA of San Diego first reported a position in HQL in Q2 2022 and held it in 8 quarters. The position peaked at $4.65K in Q3 2025. 73 funds tracked by Wall St. Rank hold HQL as of Q4 2025.

  • WFA of San Diego reported no remaining abrdn Life Sciences Investors position as of Q4 2025 after selling out during the quarter.
  • WFA of San Diego sold 300 abrdn Life Sciences Investors shares in Q4 2025, an estimated $4.65K.
  • WFA of San Diego first reported a position in abrdn Life Sciences Investors in Q2 2022 and held it in 8 quarters.
  • WFA of San Diego's abrdn Life Sciences Investors position peaked at $4.65K in Q3 2025.
  • 73 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q4 2025.

Based on WFA of San Diego's 13F filing for Q4 2025, filed 17 Feb 2026.